TMD
Results show that the COMT rs4680 (val(158)met) polymorphism is most strongly associated with outcome measures, such that individuals with the minor A allele (met) exhibit reduced COMT activity, increased TMD risk, and increased musculoskeletal pain.
Results show that the <span class="gene" id="25218601-3-22-26">COMT</span> rs4680 (val(158)met) polymorphism is most strongly associated with outcome measures, such that individuals with the minor A allele (met) exhibit reduced <span class="gene" id="25218601-3-180-184">COMT</span> activity, increased <span class="disease" id="25218601-3-205-208">TMD</span> risk, and increased musculoskeletal pain.